In conclusion, we have found that elevated FGF23 levels in CKD mice stimulate αKlotho/FGFR signalling in the parathyroid glands and induce cell proliferation in these glands, resulting in full-blown secondary hyperparathyroidism associated with CKD. The gene discussed is FGF23; the disease is secondary hyperparathyroidism.